NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 7, 2012, Pages 1170-1177

  Massone, Sara ^a   Ciarlo, Eleonora ^a   Vella, Serena ^a   Nizzari, Mario ^c   Florio, Tullio ^c   Russo, Claudio ^d   Cancedda, Ranieri ^a,b   Pagano, Aldo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

Alzheimer's disease; Beta amyloid; Neuroblastoma; Non coding RNA; RNA polymerase III

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DNA DIRECTED RNA POLYMERASE III; INTERLEUKIN 1ALPHA; NEUROBLASTOMA DIFFERENTIATION MARKER 29 PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELL DIFFERENTIATION; CEREBRAL CORTEX; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEUROBLASTOMA; NEURONS; PHENOTYPE; POSTMORTEM CHANGES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA POLYMERASE III; RNA, UNTRANSLATED;

EID: 84861465797     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.05.001     Document Type: Article

References (36)

1. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
2. Trojanowski J.Q., Lee V.M. The role of tau in Alzheimer's disease. Med. Clin. North Am. 2002, 86:615-627.
3. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:4245-4249.
4. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
5. McGeer P.L., McGeer E.G. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch. Neurol. 2001, 58:1790-1792.
6. Pratico D., Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J. Alzheimers Dis. 2004, 6:171-175.
7. Pratico D., Iuliano L., Amerio G., Tang L.X., Rokach J., Sabatino G., Violi F. Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo. Ann. Neurol. 2000, 48:795-798.
8. Pratico D., Trojanowski J.Q. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?. Neurobiol. Aging 2000, 21:441-445. discussion 451-443.
9. Venezia V., Nizzari M., Carlo P., Corsaro A., Florio T., Russo C. Amyloid precursor protein and presenilin involvement in cell signaling. Neurodegener. Dis. 2007, 4:101-111.
10. Bonda D.J., Bajic V.P., Spremo-Potparevic B., Casadesus G., Zhu X., Smith M.A., Lee H.G. Review: cell cycle aberrations and neurodegeneration. Neuropathol. Appl. Neurobiol. 2010, 36:157-163.
11. Bonda D.J., Lee H.P., Kudo W., Zhu X., Smith M.A., Lee H.G. Pathological implications of cell cycle re-entry in Alzheimer disease. Expert Rev. Mol. Med. 2010, 12:e19.
12. Raina A.K., Zhu X., Smith M.A. Alzheimer's disease and the cell cycle. Acta Neurobiol. Exp. (Wars) 2004, 64:107-112.
13. Zekanowski C., Wojda U. Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease. Acta Neurobiol Exp (Wars) 2009, 69:232-253.
14. Roe C.M., Fitzpatrick A.L., Xiong C., Sieh W., Kuller L., Miller J.P., Williams M.M., Kopan R., Behrens M.I., Morris J.C. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2005, 74:106-112.
15. Pagano A., Castelnuovo M., Tortelli F., Ferrari R., Dieci G., Cancedda R. New small nuclear RNA gene-like transcriptional units as sources of regulatory transcripts. PLoS Genet. 2007, 3:e1.
16. Castelnuovo M., Massone S., Tasso R., Fiorino G., Gatti M., Robello M., Gatta E., Berger A., Strub K., Florio T., Dieci G., Cancedda R., Pagano A. An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. FASEB J. 2010.
17. Gavazzo P., Vella S., Marchetti C., Nizzari M., Cancedda R., Pagano A. Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNA. J. Neurochem. 2011, 119:989-1001.
18. Selkoe D.J., Wolfe M.S. Presenilin: running with scissors in the membrane. Cell 2007, 131:215-221.
19. Biedler J.L., Spengler B.A. Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science 1976, 191:185-187.
20. Pagano A., Giannoni P., Zambotti A., Randazzo N., Zerega B., Cancedda R., Dozin B. CALbeta, a novel lipocalin associated with chondrogenesis and inflammation. Eur. J. Cell Biol. 2002, 264-272.
21. Pagano A., Crooijmans R., Groenen M., Randazzo N., Zerega B., Cancedda R., Dozin B. A chondrogenesis-related lipocalin cluster includes a third new gene, CALgamma. Gene 2003, 185-194.
22. Nizzari M., Venezia V., Repetto E., Caorsi V., Magrassi R., Gagliani M.C., Carlo P., Florio T., Schettini G., Tacchetti C., Russo T., Diaspro A., Russo C. Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling. J. Biol. Chem. 2007, 282:13833-13844.
23. Zerega B., Pagano A., Pianezzi A., Ulivi V., Camardella L., Cancedda R., Cancedda F.D. Expression of serum amyloid A in chondrocytes and myoblasts differentiation and inflammation: possible role in cholesterol homeostasis. Matrix Biol. 2004, 35-46.
24. Bertrand N., Castro D.S., Guillemot F. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 2002, 3:517-530.
25. Joshi S., Guleria R.S., Pan J., Dipette D., Singh U.S. Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation. Biochim. Biophys. Acta 2007, 1772:1093-1102.
26. Massone S., Vassallo I., Fiorino G., Castelnuovo M., Barbieri F., Borghi R., Tabaton M., Robello M., Gatta E., Russo C., Florio T., Dieci G., Cancedda R., Pagano A. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol. Dis. 2011, 41:308-317.
27. Mehler M.F., Mattick J.S. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol. Rev. 2007, 87:799-823.
28. St Laurent G., Faghihi M.A., Wahlestedt C. Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease. Neurosci. Lett. 2009, 466:81-88.
29. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:13363-13383.
30. Lilliehook C., Chan S., Choi E.K., Zaidi N.F., Wasco W., Mattson M.P., Buxbaum J.D. Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling. Mol. Cell. Neurosci. 2002, 19:552-559.
31. Stachel S.J., Coburn C.A., Steele T.G., Jones K.G., Loutzenhiser E.F., Gregro A.R., Rajapakse H.A., Lai M.T., Crouthamel M.C., Xu M., Tugusheva K., Lineberger J.E., Pietrak B.L., Espeseth A.S., Shi X.P., Chen-Dodson E., Holloway M.K., Munshi S., Simon A.J., Kuo L., Vacca J.P. Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase. J. Med. Chem. 2004, 47:6447-6450.
32. Sleegers K., Brouwers N., Gijselinck I., Theuns J., Goossens D., Wauters J., Del-Favero J., Cruts M., van Duijn C.M., Van Broeckhoven C. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 2006, 129:2977-2983.
33. Theuns J., Brouwers N., Engelborghs S., Sleegers K., Bogaerts V., Corsmit E., De Pooter T., van Duijn C.M., De Deyn P.P., Van Broeckhoven C. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am. J. Hum. Genet. 2006, 78:936-946.
34. Geller L.N., Potter H. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiol. Dis. 1999, 6:167-179.
35. Granic A., Padmanabhan J., Norden M., Potter H. Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP. Mol. Biol. Cell 2010, 21:511-520.
36. Bennett D.A., Leurgans S. Is there a link between cancer and Alzheimer disease?. Neurology 2010, 74:100-101.